Subject Author Posted Rep. last R. [desc] Views
Ravi 2010-04-24 06:16 5 2010-04-29 07:42 6,910
AA 2010-04-07 07:01 10 2010-04-12 07:39 22,462
mamidi.ganesh 2006-08-29 10:52 6 2010-04-09 11:58 20,829
Helmut 2010-04-06 02:58 1 2010-04-09 10:44 5,135
dixit 2010-03-21 10:19 12 2010-04-05 06:01 13,166
kev 2010-03-25 16:35 3 2010-03-26 09:42 4,475
Helmut 2010-01-11 17:14 2 2010-03-18 11:15 4,720
ioanam 2010-02-02 16:49 3 2010-02-03 12:57 5,294
yes_naresh 2009-12-28 05:44 4 2010-01-13 14:07 7,994
balakotu 2009-12-15 11:25 0   2,402
M.Vasu 2009-11-29 13:57 0   2,259
sasikumar 2008-04-03 09:19 20 2009-10-10 08:51 31,530
Nirali 2009-09-23 07:27 4 2009-10-01 09:08 12,490
yuvrajkatkar 2009-09-15 14:04 3 2009-09-18 11:55 10,106
madhurak 2009-08-28 08:47 0   2,637
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
21 visitors (0 registered, 21 guests [including 2 identified bots]).
Forum time: 19:35 CEST (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5